128.34
전일 마감가:
$130.59
열려 있는:
$130.98
하루 거래량:
2.35M
Relative Volume:
1.08
시가총액:
$36.25B
수익:
$7.23B
순이익/손실:
$1.41B
주가수익비율:
25.78
EPS:
4.979
순현금흐름:
$1.09B
1주 성능:
-5.27%
1개월 성능:
+14.90%
6개월 성능:
-7.80%
1년 성능:
+7.83%
애질런트 테크놀로지스 Stock (A) Company Profile
명칭
Agilent Technologies Inc
전화
(408) 345-8886
주소
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
A
Agilent Technologies Inc
|
128.34 | 36.88B | 7.23B | 1.41B | 1.09B | 4.979 |
|
TMO
Thermo Fisher Scientific Inc
|
472.63 | 176.04B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
181.35 | 128.18B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
IDXX
Idexx Laboratories Inc
|
573.00 | 44.96B | 4.45B | 1.10B | 1.06B | 13.59 |
|
WAT
Waters Corp
|
360.54 | 35.13B | 3.77B | 449.25M | 240.68M | 7.8556 |
애질런트 테크놀로지스 Stock (A) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-20 | 개시 | HSBC Securities | Buy |
| 2026-01-05 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-12-15 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2025-12-09 | 개시 | Goldman | Buy |
| 2025-12-02 | 개시 | Morgan Stanley | Overweight |
| 2025-10-08 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-10-08 | 업그레이드 | UBS | Neutral → Buy |
| 2025-02-10 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-07-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-06-27 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-04-05 | 업그레이드 | Stifel | Hold → Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-12-12 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-11-17 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-09-28 | 개시 | Bernstein | Mkt Perform |
| 2023-07-31 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-05-24 | 재확인 | Barclays | Equal Weight |
| 2023-05-24 | 재확인 | BofA Securities | Buy |
| 2023-05-24 | 재확인 | Citigroup | Neutral |
| 2023-05-24 | 재확인 | Credit Suisse | Outperform |
| 2023-05-24 | 재확인 | Evercore ISI | Outperform |
| 2023-05-24 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | 재확인 | Robert W. Baird | Outperform |
| 2023-05-24 | 재확인 | SVB Securities | Outperform |
| 2023-05-24 | 재확인 | Stifel | Hold |
| 2023-05-24 | 재확인 | TD Cowen | Outperform |
| 2023-05-24 | 재확인 | Wells Fargo | Overweight |
| 2023-05-11 | 개시 | Barclays | Equal Weight |
| 2023-01-10 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-07-20 | 개시 | UBS | Buy |
| 2022-07-08 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | 재확인 | BofA Securities | Buy |
| 2022-02-23 | 재확인 | Citigroup | Buy |
| 2022-02-23 | 재확인 | Cowen | Outperform |
| 2022-02-23 | 재확인 | Evercore ISI | Outperform |
| 2022-02-23 | 재확인 | Stifel | Hold |
| 2022-02-23 | 재확인 | Wells Fargo | Overweight |
| 2021-11-23 | 재확인 | BofA Securities | Buy |
| 2021-11-23 | 재확인 | Cowen | Outperform |
| 2021-11-23 | 재확인 | Stifel | Hold |
| 2021-03-18 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-02-17 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-12-02 | 개시 | Goldman | Buy |
| 2020-11-25 | 업그레이드 | UBS | Neutral → Buy |
| 2020-11-17 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | 개시 | Atlantic Equities | Neutral |
| 2020-08-19 | 재확인 | BofA Securities | Neutral |
| 2020-08-19 | 재확인 | Citigroup | Neutral |
| 2020-08-19 | 재확인 | Jefferies | Buy |
| 2020-08-19 | 재확인 | Robert W. Baird | Outperform |
| 2020-08-19 | 재확인 | SVB Leerink | Outperform |
| 2020-08-19 | 재확인 | Stifel | Hold |
| 2020-08-19 | 재확인 | Wells Fargo | Overweight |
| 2020-02-24 | 다운그레이드 | Needham | Buy → Hold |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-11-26 | 재확인 | Needham | Buy |
| 2019-11-15 | 개시 | Stifel | Hold |
| 2019-10-18 | 다운그레이드 | UBS | Buy → Neutral |
| 2019-07-16 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | 다운그레이드 | Barclays | Overweight → Equal Weight |
모두보기
애질런트 테크놀로지스 주식(A)의 최신 뉴스
Flagship focus in the lab: how Agilent’s 1290 Infinity II LC stacks up for high-end analytics - AD HOC NEWS
Agilent Technologies, Inc. (A) Stock Analysis: 23.5% Potential Upside and Strong Buy Ratings Propel Investor Interest - DirectorsTalk Interviews
Agilent stock is having its best day since 2002. Earnings leave Wall Street with ‘little to pick at.’ - MSN
Agilent 7890B GC System: robust GC workhorse for lab chromatographers - AD HOC NEWS
Agilent Technologies Q2 earnings beat estimates, revenues up Y/Y - MSN
Agilent Technologies Inc Stock (US00846U1016): Valuation metrics under the microscope after recent e - AD HOC NEWS
AAgilent Technologies Inc Stock Price and Quote - Finviz
Strength in Technology Enabled Products Drives Roper: Can the Momentum Sustain? - TradingView
Why Agilent Technologies stock triumphed on Thursday - MSN
Agilent Technologies Inc (NYSE:A): A Quality Growth Play Passes the ‘Caviar Cruise’ Screen - ChartMill
Agilent Q2 earnings call shows Ignite driving a higher outlook - MSN
Agilent Technologies Inc Stock (US00846U1016): earnings in focus after latest quarterly report - AD HOC NEWS
Why Agilent Stock Is Slipping Premarket Today - Stocktwits
Agilent Technologies Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Agilent upgraded at BofA on FQ2 beats, growth - MSN
Piper Sandler initiates Agilent stock coverage with neutral rating By Investing.com - Investing.com Nigeria
Piper Sandler Initiates Agilent Technologies(A.US) With Hold Rating, Announces Target Price $150 - Moomoo
Piper Sandler initiates Agilent stock coverage with neutral rating - Investing.com
Madison Covered Call & Equity Income Fund's Agilent Technologies Inc(A) Holding History - GuruFocus
Is Agilent Technologies stock outperforming the Nasdaq? - MSN
Agilent Technologies Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Agilent Technologies Inc. stock (US00846U1016): Life-science player updates investors after recent e - AD HOC NEWS
Agilent Partners with OpenAI and BCG to Advance Artificial Intelligence in Lab Workflows - Clinical Lab Products
Is Agilent Technologies Stock Outperforming the Nasdaq? - Barchart.com
Agilent Technologies Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Agilent Showcases Integrated Mass Spectrometry and Chromatography Solutions at ASMS 2026 - the-scientist.com
Agilent Introduces the BioTek Cytation 9 Cell Imaging Multimode Reader - Medical Product Outsourcing
Agilent Technologies Inc. stock (US00846U1016): Solid Q2 earnings and cautious outlook keep investor - AD HOC NEWS
What Puts Agilent Technologies In The Spotlight Across Markets? - Kalkine Media
Here's Why We Think Agilent Technologies (NYSE:A) Might Deserve Your Attention Today - Yahoo Finance
Agilent Technologies Inc. stock underperforms Monday when compared to competitors - MarketWatch
Agilent, OpenAI, BCG Collaborate to Accelerate Customer-Focused, AI-Driven Scientific Innovation - WebWire
Agilent introduces the 9500 Triple Quadrupole ICP-MS – Redefining trace element analysis - SelectScience
Operating income of Agilent Technologies, Inc. – XETR:AG8 - TradingView
Agilent Technologies, Inc. (A) Stock Analysis: Healthcare Giant with 18.87% Potential Upside - DirectorsTalk Interviews
Agilent Technologies, Inc. Trade Ideas — XETR:AG8 - TradingView
Agilent presents its integrated mass spectrometry and chromatography solutions at ASMS 2026 - Select Science
Number of employees of Agilent Technologies, Inc. – XETR:AG8 - TradingView
Return on invested capital % of Agilent Technologies, Inc. – XETR:AG8 - TradingView
Inventory turnover of Agilent Technologies, Inc. – XETR:AG8 - TradingView
TRADE NEWS: Agilent Technologies Announces Enhancements to Automate Verizon IMS VoIP Compliance Test - AOL.com
Agilent Technologies Inc. stock underperforms Friday when compared to competitors - MarketWatch
Agilent (NYSE: A) VP reports 8,872 share holding and RSU grant - Stock Titan
Agilent (NYSE: A) CEO surrenders 418 shares to cover RSU tax liability - Stock Titan
A Look At Agilent Technologies (A) Valuation As FDA Approval AI Deal And Earnings Update Draw Focus - Sahm
Agilent Technologies (A) Is Up 18.6% After AI Pact With OpenAI And Raised 2026 GuidanceHas The Bull Case Changed? - Yahoo Finance
Agilent lands $9M TSA contract for next-gen airport screening tech - Delaware Business Times
$Agilent Technologies (A.US)$ - Moomoo
Agilent Technologies Inc. stock (US00846U1016): shares firm after May earnings as life-science deman - AD HOC NEWS
Agilent partners with OpenAI and BCG to deploy AI solutions - Investing.com UK
Agilent (A) Partners with OpenAI and BCG to Enhance AI Capabilit - GuruFocus
애질런트 테크놀로지스 (A) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):